DV Biomed Financials
| 6539 Stock | TWD 45.95 1.75 3.96% |
6539 |
Understanding current and past DV Biomed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of DV Biomed's financial statements are interrelated, with each one affecting the others. For example, an increase in DV Biomed's assets may result in an increase in income on the income statement.
The data published in DV Biomed's official financial statements usually reflect DV Biomed's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of DV Biomed. For example, before you start analyzing numbers published by 6539 accountants, it's critical to develop an understanding of what DV Biomed's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of DV Biomed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DV Biomed's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in DV Biomed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of DV Biomed Co. Please utilize our Beneish M Score to check the likelihood of DV Biomed's management manipulating its earnings.
DV Biomed Stock Summary
DV Biomed competes with ANJI Technology, S Tech, Space Shuttle, Min Aik, and Yao Sheng. DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and internationally. The company was founded in 2011 and is based in Taipei, Taiwan. UnicoCell operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Business Address | No 63, Xingai |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | NYSE Composite |
| Website | www.dvbiomed.com |
| Phone | 886 2 2791 1826 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in DV Biomed without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of 6539 Stock, because this is throwing your money away. Analyzing the key information contained in DV Biomed's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
DV Biomed Key Financial Ratios
Generally speaking, DV Biomed's financial ratios allow both analysts and investors to convert raw data from DV Biomed's financial statements into concise, actionable information that can be used to evaluate the performance of DV Biomed over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that DV Biomed reports annually and quarterly.6539 Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining DV Biomed's current stock value. Our valuation model uses many indicators to compare DV Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across DV Biomed competition to find correlations between indicators driving DV Biomed's intrinsic value. More Info.DV Biomed Co is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for DV Biomed Co is roughly 2.66 . Comparative valuation analysis is a catch-all model that can be used if you cannot value DV Biomed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DV Biomed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the DV Biomed's earnings, one of the primary drivers of an investment's value.DV Biomed Systematic Risk
DV Biomed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. DV Biomed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifteen with a total number of output elements of fourty-six. The Beta measures systematic risk based on how returns on DV Biomed correlated with the market. If Beta is less than 0 DV Biomed generally moves in the opposite direction as compared to the market. If DV Biomed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one DV Biomed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of DV Biomed is generally in the same direction as the market. If Beta > 1 DV Biomed moves generally in the same direction as, but more than the movement of the benchmark.
About DV Biomed Financials
What exactly are DV Biomed Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include DV Biomed's income statement, its balance sheet, and the statement of cash flows. Potential DV Biomed investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although DV Biomed investors may use each financial statement separately, they are all related. The changes in DV Biomed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DV Biomed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze DV Biomed Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as DV Biomed is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of 6539 has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if DV Biomed's financials are consistent with your investment objective using the following steps:- Review DV Biomed's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand DV Biomed's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare DV Biomed's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if DV Biomed's stock is overvalued or undervalued.
DV Biomed April 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of DV Biomed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of DV Biomed Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of DV Biomed Co based on widely used predictive technical indicators. In general, we focus on analyzing 6539 Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build DV Biomed's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 70.29 | |||
| Value At Risk | (3.08) | |||
| Potential Upside | 2.97 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in DV Biomed Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for 6539 Stock analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |